These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28685525)

  • 1. Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues.
    Conti P; Caraffa Al; Kritas SK; Ronconi G; Lessiani G; Toniato E; Theoharides TC
    J Biol Regul Homeost Agents; 2017; 31(2):263-267. PubMed ID: 28685525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
    Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers.
    Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P
    J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
    Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
    J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
    Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
    Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
    Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition.
    Conti P; Lessiani G; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Tissue Cell; 2017 Jun; 49(3):393-400. PubMed ID: 28420489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
    Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 family cytokines and mast cells: activation and inhibition.
    Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators.
    Caraffa Al; Conti C; D Ovidio C; Gallenga CE; Tettamanti L; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(3):449-454. PubMed ID: 29921369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-9 and mast cells.
    Tete S; Saggini A; Maccauro G; Rosati M; Conti F; Cianchetti E; Tripodi D; Toniato E; Fulcheri M; Salini V; Caraffa A; Antinolfi P; Frydas S; Pandolfi F; Conti P; Potalivo G; Nicoletti M; Theoharides TC
    J Biol Regul Homeost Agents; 2012; 26(3):319-26. PubMed ID: 23034251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells.
    Conti P; Ronconi G; Caraffa A; Lessiani G; Duraisamy K
    Immunol Invest; 2017 Apr; 46(3):239-250. PubMed ID: 27982737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
    Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
    Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
    Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide.
    Gilchrist M; Befus AD
    Immunology; 2008 Feb; 123(2):209-17. PubMed ID: 17662042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
    Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
    Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.